Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Amortization - Intangibles (2016 - 2025)

Cumberland Pharmaceuticals' Amortization - Intangibles history spans 16 years, with the latest figure at $1.0 million for Q4 2025.

  • For Q4 2025, Amortization - Intangibles fell 30.57% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $4.0 million, down 15.03%, while the annual FY2025 figure was $4.0 million, 15.03% down from the prior year.
  • Amortization - Intangibles for Q4 2025 was $1.0 million at Cumberland Pharmaceuticals, roughly flat from $1.0 million in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $1.6 million in Q1 2022 and bottomed at $458222.0 in Q4 2022.
  • The 5-year median for Amortization - Intangibles is $1.1 million (2024), against an average of $1.1 million.
  • The largest YoY upside for Amortization - Intangibles was 46.6% in 2022 against a maximum downside of 54.95% in 2022.
  • A 5-year view of Amortization - Intangibles shows it stood at $1.0 million in 2021, then plummeted by 54.95% to $458222.0 in 2022, then soared by 156.46% to $1.2 million in 2023, then grew by 24.19% to $1.5 million in 2024, then crashed by 30.57% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Amortization - Intangibles are $1.0 million (Q4 2025), $1.0 million (Q3 2025), and $1.0 million (Q2 2025).